Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the chronic kidney disease market size evolved in recent years?
Recent years have seen strong growth in the market size of chronic kidney disease. The market is projected to increase from $70.65 billion in 2024 to $75.09 billion in 2025, showing a compound annual growth rate (CAGR) of 6.3%. Factors that drove growth in the previous period include hypertension and diabetes epidemics, an aging population, unhealthy lifestyle choices, disparities in healthcare access, and advancements in medical technology.
What are the predictions for the chronic kidney disease market size in the coming years?
Anticipated robust expansion is on the horizon for the chronic kidney disease market in the coming years. The market is projected to surge to $95.85 billion by 2029, experiencing a compound annual growth rate (CAGR) of 6.3%. Factors contributing to the growth during this projection period include emphasis on healthcare policies, evolution of precision medicine, escalating obesity statistics, increase in chronic illnesses and enhanced access to healthcare. Key trends expected to characterize this forecast period include initiatives for early detection screenings, the adoption of telemedicine and remote patient monitoring, implementation of patient empowerment programs, community-centred care strategies, and incorporation of nutritional therapy.
Get your chronic kidney disease market report here!
https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report
What key factors are fueling the growth of the chronic kidney disease market?
The escalating incidence of kidney disease is predicted to drive the expansion of the chronic kidney disease market. Kidney diseases encompass a variety of conditions that impair the functionality and structure of the kidneys. Medications for kidney diseases are utilized to regulate blood pressure, reduce protein loss to prevent further deterioration of kidney function, manage symptoms, and prevent complications. For instance, the Centers for Disease Control and Prevention, a public health agency based in the US, stated in July 2022 that nearly 15%, or 37 million individuals in the US, were suffering from kidney disease. Hence, the rising incidence of kidney disease is fueling the growth of the chronic kidney disease market.
How is the global chronic kidney disease market divided into key segments?
The chronic kidney disease market covered in this report is segmented –
1) By Diagnosis: Blood Test, Urine Test, Imaging Test, Kidney Biopsy
2) By Treatment: Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments
3) By Route of Administration: Oral, Intravenous, Subcutaneous
4) By End-User: Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users
Subsegments:
1) By Blood Test: Serum Creatinine Test, Glomerular Filtration Rate (GFR) Test, Blood Urea Nitrogen (BUN) Test, Electrolyte Tests
2) By Urine Test: Urinalysis, 24-hour Urine Collection, Urine Protein Test, Urine Albumin-To-Creatinine Ratio (ACR)
3) By Imaging Test: Ultrasound, CT Scan, MRI, X-ray
4) By Kidney Biopsy: Percutaneous Kidney Biopsy, Open Kidney Biopsy, Laparoscopic Kidney Biopsy
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11969&type=smp
Who are the key firms paving the way for growth in the chronic kidney disease market?
Major companies operating in the chronic kidney disease market include Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Mission Therapeutics Ltd., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp
Which trends are expected to transform the chronic kidney disease market?
A significant trend gaining momentum in the chronic kidney disease market is product innovations. Firms in this sector are introducing novel products to maintain their market share. For example, Bayer, a biotechnology and pharmaceutical company from Germany, launched a groundbreaking medicine named Kerendia (finerenone) in August 2022. This product, a pioneering non-steroidal, selective mineralocorticoid receptor antagonist, aims to decelerate the progression of chronic kidney disease in diabetes patients and distinguishes itself from current treatments. Its function primarily involves blocking mineralocorticoid receptor (MR) overactivation, which has been linked to CKD progression and cardiovascular damage.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11969
What regions are contributing significantly to the growth of the chronic kidney disease market?
North America was the largest region in the chronic kidney disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Styrene Butadiene Rubber (SBR) Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/styrene-butadiene-rubber-sbr-global-market-report
Ethylene Propylene (EPDM) Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/ethylene-propylene-epdm-global-market-report
Polymer Biomaterial Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/polymer-biomaterial-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
